Healthcare Equipment and Supplies
Company Overview of CHEK Diagnostics
CHEK Diagnostics designs, manufactures, and markets point-of-care diagnostics products to customers in the United States and internationally. It offers A1CNow+ and A1CNow SELF CHECK that provides glucose control average results in the office or home; PTS Detect cotinine system for tobacco-use detection with a handheld device; and PTS Pod blood collection systems. The company also provides CardioChek PA, CardioChek Plus, and CardioChek Home Cholesterol Test System analyzers that are used for cholesterol management by medical professionals; PTS Panels test strips to perform total cholesterol, HDL cholesterol, triglycerides, and glucose tests by medical professionals; PTS Panels controls that o...
7736 Zionsville Road
Indianapolis, IN 46268
Founded in 1992
Key Executives for CHEK Diagnostics
Chief Executive Officer, President and Director
President of Asia Pacific
Vice President of Technology & Development
Compensation as of Fiscal Year 2016.
CHEK Diagnostics Key Developments
PTS Diagnostics Launches PTS Detect Cotinine System
Jul 28 15
PTS Diagnostics announced that the company has launched a new product line of handheld medical devices that provide rapid point-of-care test results previously only available from a venous draw sent to a laboratory. PTS Detect™ systems will allow healthcare professionals to further expand the number of fingerstick tests with results provided at the point of care. The first product in this new family innovates tobacco-use detection. The PTS Detect cotinine system is the only point-of-care device offering quantitative results from a fingerstick. The PTS Detect cotinine system is a portable device offering specific, reliable, accurate and fast results. The PTS Detect system measures quantified cotinine (a byproduct of nicotine) levels from 25 ng/ml to 200 ng/ml in just 5 minutes. In recent evaluations, the portable PTS Detect system provided results with similar sensitivity and specificity ranges as laboratory instruments. Another benefit is the cost savings that can be realized with the PTS Detect cotinine system. As a fingerstick test, the expense of employing phlebotomists is eliminated. With no shipping of specimens to the laboratory and fewer confirmatory tests, the PTS Detect cotinine system is well-positioned for the workplace. Further, the fingerstick collection can be done in conjunction with other onsite screenings.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 2, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries